MedTrace Logo

Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance"

NCT01993927 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 742

Last updated 2018-12-04

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the safety and efficacy of long-term use of Voglibose (Basen) to prevent progression to type 2 diabetes mellitus in participants with impaired glucose tolerance in the routine clinical setting.

Conditions

  • Impaired Glucose Tolerance

Interventions

DRUG

Voglibose

Voglibose Tablets / Voglibose OD Tablets

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-18
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01993927 on ClinicalTrials.gov